300244 迪安診斷
按盤價 
20.070 -1.110 (-5.241%)
20.070 -1.110 (-5.241%) | 2026/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 7,408,609 | -2.07% | 10,096,032 | 12,196,224 | 13,408,320 | 20,282,469 | |
| 減：營業總成本 | 6,706,722 | -4.35% | 9,550,981 | 11,403,546 | 12,243,282 | 16,603,821 | |
| 其中:營業成本 | 5,154,981 | -3.93% | 7,222,146 | 8,779,607 | 9,213,383 | 12,745,811 | |
| 財務費用 | 94,708 | -1.65% | 156,601 | 198,032 | 220,608 | 298,236 | |
| 資產減值損失 | (7,072) | -1,081.71% | (96,289) | (401,579) | (16,738) | (624,025) | |
| 公允價值變動收益 | (3,274) | -128.49% | 3,528 | (12,697) | (727) | (56,236) | |
| 投資收益 | 83,419 | 525.31% | 26,194 | 38,713 | (17,596) | 48,787 | |
| 其中：對聯營企業和合營企業的投資收益 | 8,234 | 17.30% | 18,040 | 11,584 | (6,722) | 26,763 | |
| 營業利潤 | 829,531 | 191.03% | 281,315 | (31,115) | 842,183 | 2,822,609 | |
| 利潤總額 | 814,466 | 195.00% | 256,190 | (51,826) | 798,326 | 2,543,562 | |
| 減：所得稅費用 | 183,317 | 94.86% | 110,584 | 117,407 | 216,735 | 681,092 | |
| 淨利潤 | 631,150 | 246.76% | 145,606 | (169,233) | 581,591 | 1,862,470 | |
| 減：非控股權益 | 149,000 | 18.91% | 101,554 | 188,045 | 274,130 | 428,279 | |
| 股東淨利潤 | 482,149 | 750.28% | 44,053 | (357,278) | 307,461 | 1,434,191 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.789 | 750.22% | 0.072 | -0.579 | 0.492 | 2.302 | |
| 每股派息 (元) * | -- | -- | 0.350 | 0.900 | 0.060 | 0.200 | |
| 每股淨資產 (元) * | 10.754 | 3.89% | 10.308 | 10.503 | 12.069 | 11.881 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 13/11/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
